MelaMedic ApS Financials, key figures and credit report
Gross profit 443.3 kDKK FY 2024 +188.8% vs 2023
EBIT 57.4 kDKK FY 2024 -43.2% vs 2023
Net debt - 274.5 kDKK FY 2024 -323.9% vs 2023
Quick ratio 1.0 FY 2024 -0.4 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 398.01 | 559.91 | -55.04 | 153.52 | 443.30 |
| Employee benefit expenses | - 189.87 | - 260.09 | - 172.56 | -52.53 | - 385.92 |
| Total depreciation | -10.42 | -8.33 | -6.25 | ||
| EBIT | 197.73 | 291.49 | 52.54 | 100.99 | 57.38 |
| Other financial income | 0.09 | 0.01 | 0.03 | 0.17 | |
| Other financial expenses | -0.86 | -2.34 | -5.21 | -2.21 | -7.18 |
| Pre-tax profit | 196.86 | 289.25 | - 232.80 | 98.81 | 50.38 |
| Income taxes | -43.30 | -63.68 | -2.80 | 0.01 | |
| Net earnings | 153.56 | 225.56 | - 235.60 | 98.82 | 50.38 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 14.58 | 6.25 | |||
| Intangible assets total | 14.58 | 6.25 | |||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current other receivables | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 |
| Long term receivables total | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 |
| Finished products/goods | 137.91 | 296.60 | 270.59 | 290.59 | 360.47 |
| Inventories total | 137.91 | 296.60 | 270.59 | 290.59 | 360.47 |
| Current trade debtors | 175.53 | 188.59 | 14.68 | 26.07 | 43.66 |
| Current other receivables | 0.02 | 0.06 | 0.06 | ||
| Current deferred tax assets | 0.17 | ||||
| Short term receivables total | 175.53 | 188.59 | 14.87 | 26.13 | 43.71 |
| Cash and bank deposits | 149.67 | 160.16 | 115.52 | 64.75 | 274.49 |
| Cash and cash equivalents | 149.67 | 160.16 | 115.52 | 64.75 | 274.49 |
| Balance sheet total (assets) | 479.04 | 652.95 | 402.33 | 382.83 | 680.02 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -1.67 | 151.90 | 414.57 | 178.97 | 277.79 |
| Profit of the financial year | 153.56 | 225.56 | - 235.60 | 98.82 | 50.38 |
| Shareholders equity total | 191.90 | 417.46 | 218.97 | 317.79 | 368.17 |
| Provisions | 3.20 | 1.40 | -1.82 | ||
| Non-current other liabilities | 40.10 | 65.47 | 1.82 | ||
| Non-current liabilities total | 40.10 | 65.47 | 1.82 | ||
| Current loans from credit institutions | 0.17 | ||||
| Advances received | 3.96 | ||||
| Current trade creditors | 185.06 | 121.52 | 22.96 | 27.46 | 69.88 |
| Other non-interest bearing current liabilities | 58.78 | 47.11 | 156.25 | 37.57 | 241.98 |
| Current liabilities total | 243.85 | 168.63 | 183.35 | 65.03 | 311.86 |
| Balance sheet total (liabilities) | 479.04 | 652.95 | 402.33 | 382.83 | 680.02 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated